Cardiovascular Systems, Inc.
CSII
CSII was delisted on the 27th of April, 2023.
150 hedge funds and large institutions have $767M invested in Cardiovascular Systems, Inc. in 2023 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 36 increasing their positions, 56 reducing their positions, and 48 closing their positions.
57% more capital invested
Capital invested by funds: $490M → $767M (+$277M)
7% less funds holding
Funds holding: 162 → 150 (-12)
21% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 48
36% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 56
53% less call options, than puts
Call options by funds: $2.63M | Put options by funds: $5.66M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$30.1M |
| 2 |
WIC
Water Island Capital
New York
|
+$27.6M |
| 3 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$25M |
| 4 |
GF
Gabelli Funds
Rye,
New York
|
+$14.7M |
| 5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$9.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$17.7M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$16.9M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$12.8M |
| 4 |
BlackRock
New York
|
-$12.4M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$10.1M |
CSII Hedge Fund Activity: Q1 2023 in Review
150 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q1 2023, worth a combined $767M — up 57% from $490M a quarter earlier.
Sellers outnumbered buyers: 48 funds closed out of CSII and 38 opened new positions — a net loss of 10 holders — while 56 trimmed existing stakes and 36 added.
The largest buyer was Pentwater Capital Management, opening a new position worth an estimated $30.1M. The largest seller was Camber Capital Management, exiting entirely with an estimated $17.7M sold.
- 150 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q1 2023, down from 162 in Q4 2022.
- Funds reported $767M of Cardiovascular Systems, Inc. stock for Q1 2023, up 57% quarter-over-quarter.
- 38 funds opened new Cardiovascular Systems, Inc. positions in Q1 2023 and 48 closed out, a net change of -10 holders.
- The largest Cardiovascular Systems, Inc. buyer in Q1 2023 was Pentwater Capital Management, an estimated $30.1M added.
- The largest Cardiovascular Systems, Inc. seller in Q1 2023 was Camber Capital Management, an estimated $17.7M sold.
Based on aggregated 13F filings for Q1 2023.